Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients

Overview of attention for article published in Investigational New Drugs, January 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

patent: 2 patents

wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 44 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Dimensions has found 53 publications that cite this research output.

53

The most recent citing publications are shown below. View all 53 publications that cite this research output on Dimensions.

A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

Article in Science Translational Medicine (May 2023)

The Potential of Fibroblast Activation Protein-Targeted Imaging as a Biomarker of Cardiac Remodeling and Injury

Article in Current Cardiology Reports (May 2023)

Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy

Article in Drug Delivery and Translational Research (February 2023)